Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
Wainberg, Z A, Lin, L-S, DiCarlo, B, Dao, K M, Patel, R, Park, D J, Wang, H-J, Elashoff, R, Ryba, N, Hecht, J RVolume:
105
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2011.280
Date:
September, 2011
File:
PDF, 282 KB
english, 2011